These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15183116

  • 1. Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
    Ge R, Rajeev V, Subramanian G, Reiss KA, Liu D, Higgins L, Joly A, Dugar S, Chakravarty J, Henson M, McEnroe G, Schreiner G, Reiss M.
    Biochem Pharmacol; 2004 Jul 01; 68(1):41-50. PubMed ID: 15183116
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.
    Arthritis Rheum; 2004 Dec 01; 50(12):4008-21. PubMed ID: 15593186
    [Abstract] [Full Text] [Related]

  • 3. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ, Tsang D, Brown TN, Crowe DL.
    Anticancer Res; 2002 Dec 01; 22(1A):13-9. PubMed ID: 12017275
    [Abstract] [Full Text] [Related]

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 5. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
    Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.
    J Cell Physiol; 2001 Sep 01; 188(3):383-93. PubMed ID: 11473365
    [Abstract] [Full Text] [Related]

  • 6. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 01; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 7. Intracellular dynamics of Smad-mediated TGFbeta signaling.
    Greene RM, Nugent P, Mukhopadhyay P, Warner DR, Pisano MM.
    J Cell Physiol; 2003 Nov 01; 197(2):261-71. PubMed ID: 14502566
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S, Wong DH.
    Mol Pharmacol; 2007 Jul 01; 72(1):152-61. PubMed ID: 17400764
    [Abstract] [Full Text] [Related]

  • 9. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB, Yan L, Xia X, Watkins SA, Brooks HB, Beight D, Herron DK, Jones ML, Lampe JW, McMillen WT, Mort N, Sawyer JS, Yingling JM.
    Biochemistry; 2005 Feb 22; 44(7):2293-304. PubMed ID: 15709742
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
    Dunfield LD, Nachtigal MW.
    Oncogene; 2003 Jul 24; 22(30):4745-51. PubMed ID: 12879019
    [Abstract] [Full Text] [Related]

  • 11. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
    Conrotto P, Yakymovych I, Yakymovych M, Souchelnytskyi S.
    J Proteome Res; 2007 Jan 24; 6(1):287-97. PubMed ID: 17203972
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr 24; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cellular signaling in response to TGFbeta: the paradox of a factor that blocks cell proliferation and enhances metastasis].
    Vignais ML.
    Bull Cancer; 1999 Nov 24; 86(11):903-10. PubMed ID: 10586106
    [Abstract] [Full Text] [Related]

  • 15. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
    Dzwonek J, Preobrazhenska O, Cazzola S, Conidi A, Schellens A, van Dinther M, Stubbs A, Klippel A, Huylebroeck D, ten Dijke P, Verschueren K.
    Mol Cancer Res; 2009 Aug 24; 7(8):1342-53. PubMed ID: 19671686
    [Abstract] [Full Text] [Related]

  • 16. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

  • 17. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
    Liu Y, Chen L, Ko TC, Fields AP, Thompson EA.
    Oncogene; 2006 Jun 15; 25(25):3565-75. PubMed ID: 16462766
    [Abstract] [Full Text] [Related]

  • 18. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
    Warner DR, Greene RM, Pisano MM.
    FEBS Lett; 2005 Jul 04; 579(17):3539-46. PubMed ID: 15955531
    [Abstract] [Full Text] [Related]

  • 19. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
    Lu Z, Lam KS, Wang N, Xu X, Cortes M, Andersen B.
    Oncogene; 2006 May 11; 25(20):2920-30. PubMed ID: 16331278
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.
    Adnane J, Bizouarn FA, Chen Z, Ohkanda J, Hamilton AD, Munoz-Antonia T, Sebti SM.
    Oncogene; 2000 Nov 16; 19(48):5525-33. PubMed ID: 11114730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.